ArticleAntiviral research2021

Prophylactic treatment with BX795 blocks activation of AKT and its downstream targets to protect vaginal keratinocytes and vaginal epithelium from HSV-2 infection.

Krishnaraju Madavaraju et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.